Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ACTH Syndrome, Ectopic × ASP3662 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

relacorilant 5 Osilodrostat 3 Mifepristone 3 Corlux 3 Metyrapone 2 pembrolizumab 1 pasireotide 1 Staining and Labeling 1 Radiofrequency Ablation 1 Forest Therapy 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296484 2026-02-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡